|
|
|
Volumn 13, Issue 8, 2010, Pages 550-558
|
|
The formulation and immunogenicity of therapeutic proteins: Product quality as a key factor
|
|
Author keywords
Aggregate; anti drug antibody; biopharmaceutical; contaminant; drug product; immunogenicity; quality control; therapeutic protein
|
|
Indexed keywords
AMINO ACID;
BETA1A INTERFERON;
DIMER;
DIPHTHERIA PERTUSSIS TETANUS VACCINE;
DRUG ANTIBODY;
HEPATITIS B VACCINE;
HUMAN GROWTH HORMONE;
HUMAN SERUM ALBUMIN;
INTERFERON BETA SERINE;
MEASLES VACCINE;
POLIOMYELITIS VACCINE;
POLYSORBATE;
POLYSORBATE 80;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GAMMA INTERFERON;
SILICONE OIL;
SUCROSE;
SUGAR;
SURFACTANT;
ADJUVANT THERAPY;
AMINO ACID SEQUENCE;
AREA UNDER THE CURVE;
CELL AGGREGATION;
CHRONIC KIDNEY FAILURE;
CIRCULAR DICHROISM;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MANUFACTURE;
DRUG PACKAGING;
DRUG QUALITY;
DRUG SAFETY;
DRUG STABILITY;
DRUG STORAGE;
HEPATITIS B;
HUMAN;
IMMUNE RESPONSE;
IMMUNOGENICITY;
LEACHING;
LIGHT SCATTERING;
MEASLES;
MEDICAL LITERATURE;
MOLECULAR WEIGHT;
MULTIPLE SCLEROSIS;
NONHUMAN;
PHAGOCYTE;
POLIOMYELITIS;
PROPHYLAXIS;
PROTEIN ANALYSIS;
QUALITY CONTROL;
REVIEW;
SYRINGE;
TETANUS;
TREATMENT DURATION;
ANIMALS;
ANTIBODY FORMATION;
DRUG DESIGN;
EXCIPIENTS;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
QUALITY CONTROL;
RECOMBINANT PROTEINS;
|
|
EID: 77955355527
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (21)
|
|
References (9)
|
